Trials / Conditions / S-1
S-1
5 registered clinical trials studyying S-1 — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Fruquintinib Plus S-1 and Raltitrexed (RSF) for MCRC NCT06427005 | Meng Qiu | Phase 2 |
| Unknown | SOX Combined With Sintilimab and Trastuzumab Versus SOX Regimen in the Perioperative Treatment of HER2-positiv NCT05218148 | Aiping Zhou | Phase 2 |
| Unknown | Anlotinib Plus Chemotherapy for Patients With Advanced Non-small Cell Lung Cancer NCT03589950 | The First People's Hospital of Lianyungang | Phase 2 |
| Withdrawn | S-1 and Radiotherapy for Elderly Esophageal Cancer Patients NCT02716688 | Zhejiang Provincial People's Hospital | Phase 2 |
| Unknown | Attenuated SOX as First-line Treatment in Elderly Patients With Relapsed or Metastatic Gastric Cancer NCT00961077 | Soonchunhyang University Hospital | Phase 2 |